COVID-19

Although it is difficult to come up with many benefits from an unprecedented deadly global pandemic, there is one, albeit mostly inconsequential nugget that we junk science chasers at ACSH should at least acknowledge.

Indoor infectivity has been discussed in The Atlantic, 

Well, this is certainly interesting. An article from CNBC that I posted on my personal Facebook page has been flagged by Facebook fact-checkers as containing "partly false information."

A former coworker from Wyeth, let's just call him Dr. L., is not blessed with much luck (or much hair) on a good day.

Over the past few months I've been arguing that remdesivir, the only approved drug for SARS-2 infection, was never going to make a meaningful impact on COVID because it is an IV-only drug, meaning that it will only be administered to ver

For those of you needing to catch up on the story, you can look here.

This article was originally published at Geopolitical Futures. The original is here.

As I mentioned previously, I've been marooned in Poland for a few months due to the coronavirus pandemic. Poland, along with several other Eastern European countries, implemented a very severe lockdown.

The health system wants you back and rather than dwell on cash flow and other financial vagaries, the discussion is all about how the COVID-19 instituted delays, may further harm your general well-being

"Now is the winter of our discontent," begins Richard III, one of Shakespeare's most famous plays.